253 related articles for article (PubMed ID: 11378241)
1. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
[TBL] [Abstract][Full Text] [Related]
2. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
[TBL] [Abstract][Full Text] [Related]
3. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
4. Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques.
Shepherd CE; Gregory GC; Vickers JC; Brooks WS; Kwok JB; Schofield PR; Kril JJ; Halliday GM
Neurobiol Dis; 2004 Feb; 15(1):115-9. PubMed ID: 14751776
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
McNamara MJ; Gomez-Isla T; Hyman BT
Arch Neurol; 1998 Jul; 55(7):1001-4. PubMed ID: 9678319
[TBL] [Abstract][Full Text] [Related]
6. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A
Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843
[TBL] [Abstract][Full Text] [Related]
7. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
8. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
[TBL] [Abstract][Full Text] [Related]
10. Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques.
Mann DM; Takeuchi A; Sato S; Cairns NJ; Lantos PL; Rossor MN; Haltia M; Kalimo H; Iwatsubo T
Neuropathol Appl Neurobiol; 2001 Jun; 27(3):189-96. PubMed ID: 11489138
[TBL] [Abstract][Full Text] [Related]
11. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T;
Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394
[TBL] [Abstract][Full Text] [Related]
12. Alteration of cortical EEG in mice carrying mutated human APP transgene.
Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
[TBL] [Abstract][Full Text] [Related]
13. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
[TBL] [Abstract][Full Text] [Related]
14. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
15. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
Siman R; Reaume AG; Savage MJ; Trusko S; Lin YG; Scott RW; Flood DG
J Neurosci; 2000 Dec; 20(23):8717-26. PubMed ID: 11102478
[TBL] [Abstract][Full Text] [Related]
16. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
17. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.
Yasuda M; Maeda S; Kawamata T; Tamaoka A; Yamamoto Y; Kuroda S; Maeda K; Tanaka C
J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):220-3. PubMed ID: 10644793
[TBL] [Abstract][Full Text] [Related]
18. Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease.
Cairns NJ; Chadwick A; Lantos PL; Levy R; Rossor MN
Neurosci Lett; 1993 Jan; 149(2):137-40. PubMed ID: 8474686
[TBL] [Abstract][Full Text] [Related]
19. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
20. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
